MedPath

A randomised controlled trial investigating the cardiorespiratory effects of a single hypoxia-hyperoxia exposure session in elderly adults.

Not Applicable
Conditions
Elderly
Cardiovascular - Normal development and function of the cardiovascular system
Respiratory - Normal development and function of the respiratory system
Registration Number
ACTRN12624000130561
Lead Sponsor
niversidad Europea de Madrid
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Male
Target Recruitment
16
Inclusion Criteria

• Being over 60 years old.
• Having no previous experience in hypoxic training.

Exclusion Criteria

• Having any pathology that prevents the performance of physical activity.
• Subjects with impaired cognitive abilities.
• Subjects with pulmonary hypertension, decompensated heart or respiratory failure.
• Subjects who have undergone lower limb surgery within the past 12 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure will be assesed using a standard digital sphygmomanometer (Omron HEM-705CP, Omron Healthcare, Inc, Lake Forest, IL)[ Immediately before intervention and immediately after intervention];Pulmonary function will be assessed using the Air Smart Spirometer (Pond Healthcare Innovation, Sweden)[ Immediately before intervention and immediately after intervention];Heart rate variability will be assessed using a device Polar H10 (Polar Electro Oy, Kempele, Finland).[ Immediately before intervention and immediately after intervention]
Secondary Outcome Measures
NameTimeMethod
Arterial oxygen saturation will be assessed using a device Nonin® 3230 (Nonin Medical, Inc. Plymouth, MN, EEUU)[ Immediately before intervention and immediatelyafter intervention];Maximal inspiratory pressure (MIP) will be assessed using the device MicroRPM® (MicroMedical, UK).[ Immediately before intervention and immediately after intervention]
© Copyright 2025. All Rights Reserved by MedPath